45 related articles for article (PubMed ID: 23403318)
1. Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin.
Baranski Z; de Jong Y; Ilkova T; Peterse EF; Cleton-Jansen AM; van de Water B; Hogendoorn PC; Bovée JV; Danen EH
Oncotarget; 2015 Nov; 6(34):36113-25. PubMed ID: 26416351
[TBL] [Abstract][Full Text] [Related]
2. Promotion of PDT efficacy by a Bcl-2 antagonist.
Kessel D
Photochem Photobiol; 2008; 84(3):809-14. PubMed ID: 18179619
[TBL] [Abstract][Full Text] [Related]
3. Initiation of apoptosis and autophagy by the Bcl-2 antagonist HA14-1.
Kessel D; Reiners JJ
Cancer Lett; 2007 May; 249(2):294-9. PubMed ID: 17055152
[TBL] [Abstract][Full Text] [Related]
4. Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential.
Immanuel T; Li J; Green TN; Bogdanova A; Kalev-Zylinska ML
Front Oncol; 2022; 12():1010506. PubMed ID: 36330491
[TBL] [Abstract][Full Text] [Related]
5. The multiple mechanisms of MCL1 in the regulation of cell fate.
Widden H; Placzek WJ
Commun Biol; 2021 Sep; 4(1):1029. PubMed ID: 34475520
[TBL] [Abstract][Full Text] [Related]
6. TMPRSS13 promotes cell survival, invasion, and resistance to drug-induced apoptosis in colorectal cancer.
Varela FA; Foust VL; Hyland TE; Sala-Hamrick KE; Mackinder JR; Martin CE; Murray AS; Todi SV; List K
Sci Rep; 2020 Aug; 10(1):13896. PubMed ID: 32807808
[TBL] [Abstract][Full Text] [Related]
7. Targeting the Bcl-2 Family in B Cell Lymphoma.
Adams CM; Clark-Garvey S; Porcu P; Eischen CM
Front Oncol; 2018; 8():636. PubMed ID: 30671383
[TBL] [Abstract][Full Text] [Related]
8. ABT-199 (Venetoclax), a BH3-mimetic Bcl-2 inhibitor, does not cause Ca
Jakubowska MA; Kerkhofs M; Martines C; Efremov DG; Gerasimenko JV; Gerasimenko OV; Petersen OH; Bultynck G; Vervliet T; Ferdek PE
Br J Pharmacol; 2019 Nov; 176(22):4402-4415. PubMed ID: 30266036
[TBL] [Abstract][Full Text] [Related]
9. Emerging molecular mechanisms in chemotherapy: Ca
Kerkhofs M; Bittremieux M; Morciano G; Giorgi C; Pinton P; Parys JB; Bultynck G
Cell Death Dis; 2018 Feb; 9(3):334. PubMed ID: 29491433
[TBL] [Abstract][Full Text] [Related]
10. On BH3 Mimetics and Ca
Ferdek PE; Jakubowska MA
Drug Dev Res; 2017 Sep; 78(6):313-318. PubMed ID: 28804913
[TBL] [Abstract][Full Text] [Related]
11. BH3 mimetic-elicited Ca
Ferdek PE; Jakubowska MA; Nicolaou P; Gerasimenko JV; Gerasimenko OV; Petersen OH
Cell Death Dis; 2017 Mar; 8(3):e2640. PubMed ID: 28252652
[TBL] [Abstract][Full Text] [Related]
12. Bcl-2 proteins and calcium signaling: complexity beneath the surface.
Vervliet T; Parys JB; Bultynck G
Oncogene; 2016 Sep; 35(39):5079-92. PubMed ID: 26973249
[TBL] [Abstract][Full Text] [Related]
13. BH4 domain of Bcl-2 as a novel target for cancer therapy.
Liu Z; Wild C; Ding Y; Ye N; Chen H; Wold EA; Zhou J
Drug Discov Today; 2016 Jun; 21(6):989-96. PubMed ID: 26631752
[TBL] [Abstract][Full Text] [Related]
14. HA14-1, but not the BH3 mimetic ABT-737, causes Ca2+ dysregulation in platelets and human cell lines.
Akl H; Vandecaetsbeek I; Monaco G; Kauskot A; Luyten T; Welkenhuyzen K; Hoylaerts M; De Smedt H; Parys JB; Bultynck G
Haematologica; 2013 Apr; 98(4):e49-51. PubMed ID: 23403318
[No Abstract] [Full Text] [Related]
15. Apoptosis sensitizers enhance cytotoxicity in hepatoblastoma cells.
Lieber J; Ellerkamp V; Wenz J; Kirchner B; Warmann SW; Fuchs J; Armeanu-Ebinger S
Pediatr Surg Int; 2012 Feb; 28(2):149-59. PubMed ID: 21971946
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule Bcl-2 inhibitors sensitise tumour cells to immune-mediated destruction.
Lickliter JD; Cox J; McCarron J; Martinez NR; Schmidt CW; Lin H; Nieda M; Nicol AJ
Br J Cancer; 2007 Feb; 96(4):600-8. PubMed ID: 17311012
[TBL] [Abstract][Full Text] [Related]
17. BH3-mimetic ABT-737 induces strong mitochondrial membrane depolarization in platelets but only weakly stimulates apoptotic morphological changes, platelet shrinkage and microparticle formation.
Gyulkhandanyan AV; Mutlu A; Allen DJ; Freedman J; Leytin V
Thromb Res; 2014 Jan; 133(1):73-9. PubMed ID: 24268298
[TBL] [Abstract][Full Text] [Related]
18. [Progress in small-molecule inhibitors of Bcl-2 family proteins].
Tang Y; Zhang DY; Wu XM
Yao Xue Xue Bao; 2008 Jul; 43(7):669-77. PubMed ID: 18819468
[TBL] [Abstract][Full Text] [Related]
19. Targeting multiple arms of the apoptotic regulatory machinery.
Dai Y; Grant S
Cancer Res; 2007 Apr; 67(7):2908-11. PubMed ID: 17409392
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
